CRISPR makes prostate cancer vulnerable to immunotherapy
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.
Read the full story at ScienceDaily Health →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.

